ES2026534T3 - Dispositivo para liberacion de drogas, su preparacion y uso. - Google Patents

Dispositivo para liberacion de drogas, su preparacion y uso.

Info

Publication number
ES2026534T3
ES2026534T3 ES87304890T ES87304890T ES2026534T3 ES 2026534 T3 ES2026534 T3 ES 2026534T3 ES 87304890 T ES87304890 T ES 87304890T ES 87304890 T ES87304890 T ES 87304890T ES 2026534 T3 ES2026534 T3 ES 2026534T3
Authority
ES
Spain
Prior art keywords
drugs
release
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87304890T
Other languages
English (en)
Inventor
Peter William Berry
Paul Holden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith and Nephew PLC
Original Assignee
Smith and Nephew PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868613382A external-priority patent/GB8613382D0/en
Priority claimed from GB868619702A external-priority patent/GB8619702D0/en
Priority claimed from GB868620226A external-priority patent/GB8620226D0/en
Priority claimed from GB878706780A external-priority patent/GB8706780D0/en
Application filed by Smith and Nephew PLC filed Critical Smith and Nephew PLC
Application granted granted Critical
Publication of ES2026534T3 publication Critical patent/ES2026534T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
ES87304890T 1986-06-03 1987-06-03 Dispositivo para liberacion de drogas, su preparacion y uso. Expired - Lifetime ES2026534T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB868613382A GB8613382D0 (en) 1986-06-03 1986-06-03 Drug delivery device
GB868619702A GB8619702D0 (en) 1986-08-13 1986-08-13 Drug delivery service
GB868620226A GB8620226D0 (en) 1986-08-20 1986-08-20 Drug delivery device
GB878706780A GB8706780D0 (en) 1986-06-03 1987-03-02 Drug delivery device

Publications (1)

Publication Number Publication Date
ES2026534T3 true ES2026534T3 (es) 1992-05-01

Family

ID=27449775

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87304890T Expired - Lifetime ES2026534T3 (es) 1986-06-03 1987-06-03 Dispositivo para liberacion de drogas, su preparacion y uso.

Country Status (8)

Country Link
US (1) US4784857A (es)
EP (1) EP0250125B1 (es)
JP (1) JP2585600B2 (es)
AU (1) AU609398B2 (es)
CA (1) CA1272922A (es)
DE (1) DE3773057D1 (es)
ES (1) ES2026534T3 (es)
GB (1) GB2191943B (es)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6139868A (en) * 1986-08-28 2000-10-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
US5820876A (en) 1986-08-28 1998-10-13 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system
USRE37934E1 (en) 1986-08-28 2002-12-10 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system
US6126963A (en) * 1986-08-28 2000-10-03 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
US6117448A (en) * 1986-08-28 2000-09-12 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
US6110488A (en) * 1986-08-28 2000-08-29 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system, its use and production process
US4915950A (en) * 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
US4906475A (en) 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US5008110A (en) * 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
JPH0659291B2 (ja) * 1988-12-10 1994-08-10 日本特許管理株式会社 経皮吸収薬
WO1990006120A1 (en) * 1988-12-01 1990-06-14 Schering Corporation Compositions for transdermal delivery of estradiol
US5248295A (en) * 1989-05-08 1993-09-28 Iomed, Inc. Bioelectrode seal
ES2017282A6 (es) * 1989-07-28 1991-01-16 Aguilera Franco Maria Aposito para aplicaciones de substancias activas por via transcutanea con fines terapeuticos o cosmeticos.
FR2650747B1 (fr) * 1989-08-11 1994-02-11 Oreal Film composite pour traitement cutane local et procedes de fabrication correspondants
US5091186A (en) * 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
US5192536A (en) * 1990-10-26 1993-03-09 Huprich Carl A Method and composition for coating a wound with polyether polyurethane
JPH04272773A (ja) * 1991-02-26 1992-09-29 Eitetsu Tokusawa 静脈注射用局部麻酔剤投与シート
GB9105977D0 (en) * 1991-03-21 1991-05-08 Smith & Nephew Percutaneous anaesthesia
US5273756A (en) * 1991-08-23 1993-12-28 Cygnus Therapeutic Systems Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset
US5273755A (en) * 1991-08-23 1993-12-28 Cygnus Therapeutic Systems Transdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset
US5234690A (en) * 1991-08-23 1993-08-10 Cygnus Therapeutic Systems Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
AU666735B2 (en) * 1992-05-13 1996-02-22 Alza Corporation Transdermal administration of oxybutynin
WO1993024627A1 (en) * 1992-06-03 1993-12-09 Case Western Reserve University Bandage for continuous application of biologicals
EP0642779A1 (en) * 1993-09-13 1995-03-15 E.R. Squibb & Sons, Inc. Wound filler
US5962011A (en) * 1993-12-06 1999-10-05 Schering-Plough Healthcare Products, Inc. Device for delivery of dermatological ingredients
US5399359A (en) * 1994-03-04 1995-03-21 Edward Mendell Co., Inc. Controlled release oxybutynin formulations
US5635203A (en) * 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
US5730721A (en) * 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
EP0998274B1 (en) * 1997-06-23 2006-01-18 Cellegy Pharmaceuticals, Inc Microdose therapy of vascular conditions by no donors
US6660295B2 (en) 1997-09-30 2003-12-09 Alza Corporation Transdermal drug delivery device package with improved drug stability
SE512224C2 (sv) * 1998-06-26 2000-02-14 Medeikonos Ab Anordning för applicering av deltaaminolevulinsyra (ALA) på huden vid cancerdetektering och för skyddande av det med ALA-applicerade hudområdet mot lus
US6183770B1 (en) 1999-04-15 2001-02-06 Acutek International Carrier patch for the delivery of agents to the skin
JP2001048783A (ja) * 2000-01-01 2001-02-20 Lead Chemical Co Ltd 経皮吸収型頻尿・尿失禁治療剤
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
CA2440141A1 (en) 2001-03-06 2002-09-12 Cellegy Pharmaceuticals, Inc. Compounds and methods for the treatment of urogenital disorders
US6676961B1 (en) 2002-03-06 2004-01-13 Automated Carrier Technologies, Inc. Transdermal patch assembly
CA2496798A1 (en) 2002-08-30 2004-03-11 Alza Corporation Embossable and writable multilaminate backing construction
US20040214215A1 (en) * 2003-03-07 2004-10-28 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
US20040220264A1 (en) * 2003-03-17 2004-11-04 Yu Ruey J Bioavailability and improved delivery of acidic pharmaceutical drugs
EP1670433B1 (en) 2003-10-10 2011-11-23 Antares Pharma IPL AG Transdermal pharmaceutical formulation for minimizing skin residues
US20050196418A1 (en) * 2004-03-04 2005-09-08 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
US20050202073A1 (en) * 2004-03-09 2005-09-15 Mylan Technologies, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
EP1802775B1 (en) 2004-09-14 2010-05-26 The Regents of the University of Colorado Method for treatment with bucindolol based on genetic targeting
JP3986525B2 (ja) 2004-12-27 2007-10-03 株式会社 アグル 経皮貼り剤及びその製造方法
WO2007124250A2 (en) 2006-04-21 2007-11-01 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
US20070118084A1 (en) * 2005-11-21 2007-05-24 Grossman Leonard D Dressing for treatment of cellulitis
US20070116749A1 (en) * 2005-11-21 2007-05-24 Grossman Leonard D Method for treatment of cellulitis
GB0606661D0 (en) 2006-04-03 2006-05-10 Brightwake Ltd Improvements relating to dressings
JP4820202B2 (ja) * 2006-04-19 2011-11-24 株式会社カナエ 経皮吸収薬剤保持容器ならびに経皮吸収薬投薬デバイス
US20070258935A1 (en) * 2006-05-08 2007-11-08 Mcentire Edward Enns Water dispersible films for delivery of active agents to the epidermis
US20070259029A1 (en) * 2006-05-08 2007-11-08 Mcentire Edward Enns Water-dispersible patch containing an active agent for dermal delivery
US20080057090A1 (en) * 2006-09-01 2008-03-06 Mcentire Edward Enns Wrinkle masking film composition for skin
US7879942B2 (en) 2006-10-05 2011-02-01 Eastman Chemical Company Switchable adhesive article for attachment to skin and method of using the same
DE102007006244B4 (de) * 2007-02-08 2012-03-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System zur Verabreichung wasserlöslicher Wirkstoffe
CA2774993A1 (en) * 2008-09-26 2010-04-01 Suzana Hillhouse Transdermal delivery device and method
WO2010048064A2 (en) * 2008-10-20 2010-04-29 The Brigham And Women's Hospital, Inc. Drug delivery system and its use in the treatment of postherpetic neuralgia
US8920392B2 (en) * 2009-05-05 2014-12-30 Watson Laboratories, Inc. Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions
WO2011006922A1 (en) * 2009-07-14 2011-01-20 Sanofi-Aventis Deutschland Gmbh Medicament container with a flexible inner layer and a rigid outer layer
US9512481B2 (en) 2009-09-11 2016-12-06 The Regents Of The University Of Colorado, A Body Corporate Polymorphisms in the PDE3A gene
DE102009056745A1 (de) * 2009-12-04 2011-06-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung von Peptiden
CA2822747A1 (en) 2009-12-23 2011-06-30 Arca Biopharma, Inc. Use of s-(6-nitro-oxi-hexahydro-furo[3,2-b]thioacetate in the treatment of cardiovascular disorders associated with oxide synthase dysfunction
GB2493960B (en) 2011-08-25 2013-09-18 Brightwake Ltd Non-adherent wound dressing
CN104039306B (zh) 2011-12-15 2016-09-21 高露洁-棕榄公司 含有聚氨酯-34的清洁组合物
KR200474667Y1 (ko) * 2012-01-20 2014-10-14 이영희 약액 및 배액세트 연결구

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE638231A (es) * 1962-03-16
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3875300A (en) * 1972-12-18 1975-04-01 Ortho Pharma Corp Composition for sustained release of a medicament and method of using same
US4136145A (en) * 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
US4136162A (en) * 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
JPS57139348U (es) * 1981-02-26 1982-08-31
JPS59141532U (ja) * 1983-03-14 1984-09-21 ニチバン株式会社 医療用貼付剤
JPS59157431U (ja) * 1983-04-04 1984-10-22 ニチバン株式会社 医療用貼付剤
US4605548A (en) * 1983-05-31 1986-08-12 Nitto Electric Industrial Co., Ltd. Drug administration material
US4573996A (en) * 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
US4638043A (en) * 1984-11-13 1987-01-20 Thermedics, Inc. Drug release system
JPS61293911A (ja) * 1985-06-24 1986-12-24 Teisan Seiyaku Kk 徐放化製剤

Also Published As

Publication number Publication date
GB2191943B (en) 1991-02-13
AU609398B2 (en) 1991-05-02
EP0250125B1 (en) 1991-09-18
CA1272922A (en) 1990-08-21
AU7378987A (en) 1987-12-10
JPS6329661A (ja) 1988-02-08
DE3773057D1 (de) 1991-10-24
JP2585600B2 (ja) 1997-02-26
US4784857A (en) 1988-11-15
EP0250125A3 (en) 1989-04-19
GB2191943A (en) 1987-12-31
EP0250125A2 (en) 1987-12-23
GB8712975D0 (en) 1987-07-08

Similar Documents

Publication Publication Date Title
ES2026534T3 (es) Dispositivo para liberacion de drogas, su preparacion y uso.
MX9845A (es) Propanaminas 3-ariloxi-3-substituidas y procedimiento para su preparacion.
MX7372A (es) Drivados de tetrahidronaftalina e indano y procedimiento para su preparacion.
MX10621A (es) Compuestos de piperazinil heterociclicos y procedimiento para su preparacion.
ES2017922B3 (es) 3-amino-4,5-dihidroxipiperidinas, procedimiento para su preparacion, y su empleo.
MX14910A (es) 2',3' -dideoxi-2',2'-difluoronucleosidos y procedimiento para su preparacion.
MX24568A (es) 3-arilcarbonil-1h-indoles y procedimiento para su preparacion.
MX20476A (es) Composiciones de polipropileno y procedimiento para su preparacion.
MX16687A (es) Compuestos de biarilo y procedimiento para su preparacion.
MX15701A (es) Composiciones de macrolidas y procedimiento para su preparacion.
MX7769A (es) Procedimiento para la preparacion de derivados de pirimidina.
ES2022454B3 (es) Sistema terapeutico para la liberacion controlada de drogas.
MX26267A (es) Aminobenzodiacepinas y procedimiento para su prepaacion.
MX9202818A (es) Nuevos tiazoles y oxazoles y procedimiento para su preparacion.
PT8397T (pt) Dispositivo quimiluminescente para uso de emergencia
MX22255A (es) Compuestos de piridinil-quinolona y procedimiento para su preparacion.
MX21243A (es) Indenoindoles y procedimiento para su preparacion.
MX14002A (es) Pigmentos monoazoicos, procedimientos para su preparacion, y su utilizacion
MX7829A (es) Quinazolindionas y piridopirimindionas y procedimiento para su preparacion
MX17041A (es) Procedimiento para la preparacion de benzopirano pirazoles.
MX9102792A (es) D-aminoacido-axidasa inmovilizada y su empleo para la preparacion de medicamentos.
MX15050A (es) Procedimiento para la preparacion de derivados de 1-arilsulfinil-2-pirrolidinona.
IT8621695A0 (it) Preparazione farmaceutica per uso veterinario.
MX25777A (es) N-hateroaril-4-quinolinaminas, un procedimiento para su preparacion y su uso como medicamentos.
NO901424L (no) Fremgangsmaate for fremstilling av selektive adenosinreseptorforbindelser.